Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
H1 2020 results
-
Farxiga met all primary and secondary endpoints in groundbreaking Phase III DAPA-CKD trial for the treatment of patients with chronic kidney disease
-
Calquence recommended for approval in the EU by CHMP for chronic lymphocytic leukaemia
-
Imfinzi recommended for approval in the EU by CHMP for extensive-stage small cell lung cancer
-
AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise new antibody drug conjugate
-
Breztri Aerosphere approved in the US for the maintenance treatment of COPD
-
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
-
Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design
-
Brilinta significantly reduced the rate of the composite of stroke and death in patients who had an acute ischaemic stroke or transient ischaemic attack in the Phase III THALES trial
-
Brilinta granted FDA Priority Review for the reduction of subsequent stroke in patients who had an acute ischemic stroke or transient ischemic attack
Latest articles and press releases
All of our latest press releases and articles are available to explore
